Received Sep 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | 2 | — | — |
diagnosed with SVT with her heart in February 2022; This spontaneous case was reported by a consumer and describes the occurrence of SUPRAVENTRICULAR TACHYCARDIA (diagnosed with SVT with her heart in February 2022) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis. Previously administered products included for Product used for unknown indication: Janssen COVID-19 vaccine (Dose 1) on 10-Mar-2021. Past adverse reactions to the above products included No adverse effect with Janssen COVID-19 vaccine. Concurrent medical conditions included Crohn's, Colitis and Disability NOS. On 26-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced SUPRAVENTRICULAR TACHYCARDIA (diagnosed with SVT with her heart in February 2022). At the time of the report, SUPRAVENTRICULAR TACHYCARDIA (diagnosed with SVT with her heart in February 2022) outcome was unknown. No concomitant medication was reported. It was reported that when Johnson and Johnson COVID vaccine was no longer available, patient started getting the Moderna COVID vaccine. The patient received Moderna vaccines on 31-Mar-2022 and on 20-Sep-2022. Two other doses were not documented on shot record but on a vaccine sheet patient had received. The patient was considered high risk as she had an underlying condition and was disabled. The patient had Crohn's and other health issues which were pre-existing before any COVID vaccine, however she was diagnosed with SVT with her heart in February 2022. It was reported that this condition might have pre-existed as patient went to the hospital and they diagnosed it, patient had the same symptoms her entire life and they always diagnosed it as she was having an anxiety attack. The reporter stated that the symptoms would not stop, and patient had been since diagnosed with SVT. No treatment information was provided. This case was linked to US-MODERNATX, INC.-MOD-2025-789363 (E2B Linked Report).; Reporter's Comments: In view of the long non-suggestive onset latency the causality of the event was assessed as not related to the vaccine. The benefit -risk relationship of product is not affected by this report.; Sender's Comments: US-MODERNATX, INC.-MOD-2025-789363:Reporter's daughter case
Colitis; Crohn's; Disability NOS